The urgent call of albuminuria/proteinuria: Heeding its significance in early detection of kidney disease

Postgraduate Medicine

Volumn 110, Issue 4, 2001, Pages

  Hebert, Lee A ^a   Spetie, Dan N ^a   Keane, William F ^b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BENAZEPRIL; CAPTOPRIL; CREATININE; CYANOCOBALAMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOLIC ACID; RAMIPRIL;

ALGORITHM; CARDIOVASCULAR RISK; CLINICAL EXAMINATION; CONFERENCE PAPER; CREATININE BLOOD LEVEL; DIABETES MELLITUS; HUMAN; HYPERTENSION; KIDNEY FAILURE; PATHOPHYSIOLOGY; PRIMARY MEDICAL CARE; PROTEIN URINE LEVEL; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT;

EID: 0034796011     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2001.10.1047     Document Type: Conference Paper

References (14)

1. Proteinuria: Its clinical importance and role in progressive renal disease
2. Laboratory assessment of renal disease: Clearance, urinalysis, and renal biopsy
3. Proteinuria selectivity index based upon alpha 2-macroglobulin or IgM is superior to the IgG based index in differentiating glomerular diseases
4. Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): A position paper of the National Kidney Foundation
5. Renoprotection: One or many therapies?
6. Remission of nephrotic syndrome in type 1 diabetes: Long-term follow-up of patients in the Captopril Study
7. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial
8. Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease
9. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease
10. Preserving renal function in adults with hypertension and diabetes: A consensus approach
11. Endothelial cell dysfunction and nitric oxide synthase
12. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
13. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy